Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Use of Flutter VRP1 in the management of patients with steroid-dependent asthma

Swift, G. L., Rainer, Timothy, Saran, R., Campbell, I. A. and Prescott, R. J. 1994. Use of Flutter VRP1 in the management of patients with steroid-dependent asthma. Respiration 61 (3) , pp. 126-129. 10.1159/000196323

Full text not available from this repository.


We have assessed a new positive expiratory pressure device, the Flutter VRP1, in 20 patients with moderately severe asthma. Patients were studied for an initial 1-week ‘run-in’ period, followed by 2 weeks of the flutter device in one of which the ball-bearing was removed from the bowl. Peak expiratory flow rates, salbutamol inhaler requirements and visual analogue scores were recorded daily. Ease of sputum expectoration showed a significant improvement after 6 days of the flutter device, but there were no differences in objective measurements of lung function nor in salbutamol use. The device may be a useful adjunct to asthma therapy.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Uncontrolled Keywords: Asthma; Positive end-expiratory pressure
Publisher: Karger
ISSN: 0025-7931
Date of Acceptance: 27 January 1994
Last Modified: 04 Jun 2017 09:16

Citation Data

Cited 20 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item